Resistin, Obesity, and Insulin Resistance — The Emerging Role of the Adipocyte as an Endocrine Organ
- 1 November 2001
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (18) , 1345-1346
- https://doi.org/10.1056/nejm200111013451814
Abstract
One hundred years ago, type 2 diabetes mellitus was considered a rare disease, but recently there has been an explosive increase in its incidence. About 16 million Americans have type 2 diabetes,1 and at least an equal number have impaired glucose tolerance. Insulin resistance and hyperinsulinemia are characteristics of both type 2 diabetes and impaired glucose tolerance. These metabolic derangements, combined with the hypertension and dyslipidemia that are common in type 2 diabetes and impaired glucose tolerance, markedly increase the risk of cardiovascular, peripheral vascular, and cerebrovascular disease.Why has the incidence of type 2 diabetes increased so rapidly? Considerable . . .Keywords
This publication has 5 references indexed in Scilit:
- Dimerization of Resistin and Resistin-like Molecules Is Determined by a Single CysteineJournal of Biological Chemistry, 2001
- A Cysteine-rich Adipose Tissue-specific Secretory Factor Inhibits Adipocyte DifferentiationJournal of Biological Chemistry, 2001
- The hormone resistin links obesity to diabetesNature, 2001
- Adipose Tissue as an Endocrine OrganTrends in Endocrinology & Metabolism, 2000
- Early detection of undiagnosed diabetes mellitus: a US perspectiveDiabetes/Metabolism Research and Reviews, 2000